A detailed history of Two Sigma Securities, LLC transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 11,027 shares of ELDN stock, worth $48,077. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,027
Holding current value
$48,077
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.41 - $3.19 $26,575 - $35,176
11,027 New
11,027 $27,000
Q4 2023

Feb 14, 2024

BUY
$1.12 - $1.86 $13,193 - $21,910
11,780 New
11,780 $21,000

Others Institutions Holding ELDN

About Eledon Pharmaceuticals, Inc.


  • Ticker ELDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,756,800
  • Market Cap $60M
  • Description
  • Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...
More about ELDN
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.